• Share
  • Email
  • Print

Jackson Ho, Ph.D.

Partner
+1.650.798.6719
Fax +1.650.798.6701

Jackson Ho is a PTO-registered patent litigator with a Ph.D. in Molecular and Cell Biology, and a background in chemical engineering.  He focuses on patent litigation involving in a wide array of technologies, including biotechnology, pharmaceuticals, nutraceuticals, medical devices, digital cameras, security systems, home automation, Internet firewalls and malware detection systems, food products, and lab instrumentation. He has experience litigating cases in the Eastern District of Texas, Northern District of California, District of Delaware, District of Massachusetts, and the International Trade Commission, among others.

Mr. Ho is experienced in all phases of patent litigation, including motions to transfer venue, motions to dismiss, fact and expert discovery, claim construction, dispositive motion practice, trial preparation, trial, and post-trial briefing. Mr. Ho has also been involved in the filing of inter partes review (IPR) petitions in the United States Patent and Trademark Office.

  • DSM v. Archer Daniels Midland Co. (N.D. Ill.) — Represented ADM against a global company defending an infringement action in the N.D. Ill. concerning astaxanthin feed products. Obtained favorable settlement prior to trial.
  • Trivitis, Inc. v. Ocean Spray Cranberries, Inc. (S.D. Cal.) – Represented Ocean Spray Cranberries, a beverage supplements and nutraceuticals company, in a patent infringement case securing  summary judgment of non-infringement.
  • StemCells, Inc. v. Neuralstem, Inc. (D. Md.) — Representing Neuralstem in patent litigation matter involving six patents related to neural stem cells and methods of culturing the same in serum-free medium.  Decision pending on bench trial held in December 2014.
  • CytoLogix Corp. v. Ventana Medical Systems, Inc. (D. Mass.) – Represented CytoLogix in numerous actions adverse to Ventana concerning slide based cellular diagnostics. As plaintiff, we recovered $49 million in a publicly disclosed settlement. As defendant, we received dismissals, obtained settlements, and paid no damages.
  • In the matter of Certain Coenzyme Q10 Products and Methods of Making Same, Inv. No. 337-TA-790 (USITC) — Representing respondent Shenzhou Biology and Technology Co., Ltd. against Kaneka Corporation in ITC Investigation involving process patent relating to industrial microbiology and vitamin production.
  • Fiberweb Simpsonville (and related entities) v. Baldwin Graphic Systems, Inc. (D. Del.) – Represented Fiberweb in a multinational patent dispute regarding nonwoven manufacturing and fabrics. We obtained favorable settlement on the heels of a successful Markman hearing.
  • CareFusion 303, Inc. v. Sigma International. (S.D. Cal.) Represented Sigma International (a Baxter Healthcare subsidiary) in a two-week jury trial in the Southern District of California resulting in a verdict of non-infringement of a patent relating to intravenous infusion pump technology.  The case was named a 2012 top defense verdict in California by the Daily Journal.
  • Skyworks v. Kinetic Technologies (D. Mass) — Represented Kinetic Technologies in patent litigation case securing dismissal based on lack of personal jurisdiction.